As of 8 AM ET on Friday morning, Alaska: Donald Trump still leads after no new votes were reported overnight.Arizona: Joe Biden is still holding onto a 47,052 vote advantage after a 75,000 vote update from Maricopa County and several small updates came in overnight. About 275,000 ballots are still thought to be outstanding. To win the state, Trump would have to take those votes by around 56%, which is pretty much on track with what has happened so far in post-election tallies. However, there are reasons to believe that the votes remaining are less Trump friendly. In any case, it’s likely to be close.- Advertisement – – Advertisement – At this point, it’s possible that the the promise of Pennsylvania votes coming in “any minute” may simply be burned into the screen. And yes, it is possible to be both supportive of the volunteers who stayed at their posts overnight, flipping through mail-in ballots under the eye of watching cameras and bipartisan observers, while still being frustrated that we haven’t seen the outcome of that work.But we should be getting more votes from Pennsylvania … any minute now.- Advertisement – Pennsylvania: Is, of course, the ballgame. Biden could lose all the other remaining states if he took home Pennsylvania. With Pennsylvania, Arizona, North Carolina, and Nevada, Biden would lock up a substantial victory that rebuilt the “blue wall,” made a foray into the South, and added a new wall across the Sunbelt from California to New Mexico. Overnight, Biden added about 43,000 votes to Trump’s 13,000. A similar ratio is expected across the remaining votes, which should easily reverse the 18,000 vote edge Trump currently holds. The status of Pennsylvania really could change … any minute now.Meanwhile, the Secret Service has increased its protection over Joe Biden and Kamala Harris. Like the FAA’s setting of a protective circle around Biden’s home, this isn’t an official confirmation. But it is a sign that behind the scenes the people who are responsible for protecting the president, believe that title if going to go to Biden.Oh, and also Donald Trump made a speech that was all lies, horribly corrosive to the nation, and openly encouraging of authoritarian actions and violence. As expected. Georgia: Biden has pulled out to a 1,096 vote advantage. There are roughly 10,000 ballots remaining, however these might not include around 7,000 military ballots and expat ballots that could arrive as late as today. In any case, Biden’s advantage here will likely grow, but don’t expect a call on the state until things are a little more definitive.Nevada: Biden has an edge of 11,438 votes. About 51,000 votes remaining from highly Democratic Clark County, which is why so much legal attention from Trump’s team is focused on the pretense that the voting there is somehow “illegal.” That includes an illegal use of the postal database to suggest that there are voters who have changed residence but still voted in Clark County, and the use of a woman who claims to be a victim of voter fraud, but may be the only known case of someone actually trying to vote twice in the whole state. In any case, expect Biden’s edge to grow when more votes are added around 2PM ET — at which point the state may be called.North Carolina: No change overnight, with Trump still holding a 76,000 vote advantage. There’s no reason to believe what’s still outstanding in the state will add it to team blue, though some people are feeling more hopeful after seeing the slow trend toward Biden in Georgia.- Advertisement –
– Advertisement – A gender inequality row has erupted in football after the FA doubled down on its decision to close girls’ academies during lockdown while boys’ academies have been allowed to remain open.The move has sparked anger and concern in the women’s game, particularly as it closely follows the decision to halt the women’s FA Cup until after lockdown is over, while the equivalent men’s competition has been given the green light to continue, despite also involving non-elite teams.- Advertisement – It is understood that the government would have allowed girls academies to remain open, as per their guidance which stipulates that an elite athlete is any person “aged 16 or above on an elite development pathway”. Alex Culvin, a former professional footballer and now a lecturer in sport business at the University of Salford, told Sky News the decision was “ridiculous and separatist and indicative of the FA’s interpretation of women’s football”.Leading football pundit and former player Alex Scott also said she would work to get answers about the FA’s decision.“We must do everything to stop inequality like this,” she wrote on social media.Sky News has contacted the FA for further comment. This issue has rightfully been flagged to me today. Will do all I can to look into this and get some answers. We must do everything to stop inequality like this in our amazing game whilst simultaneously ensuring the safety of everyone. https://t.co/ZVXLs9YMbq— Alex Scott MBE (@AlexScott) November 6, 2020 “I don’t know who makes these decisions but they clearly don’t realise how far the women’s game has come,” Helen Ward, a footballer for Watford FC Women, told Sky News.“I can’t get my head around it, it sends a really bad message and instils the belief in the next generation that boys’ football is more important than girls’.”The FA said in a statement after the controversy erupted that all academies belonging to Womens’ Super League clubs would have to remain closed until at least the end of the national lockdown on 2 December, because it deemed their resources “do not meet the necessary ‘elite’ protocols”.- Advertisement – But boys’ academies, some of them based within the same facilities, will be allowed to remain open.“I think it is hard to say it’s anything other than gender inequality,” said Ward.“It shows a total lack of regard for the women’s game and we risk losing young girls to the sport forever because four weeks is a long time off.”- Advertisement –
– Advertisement – Trailblazers – Advertisement – 14:00 Day 1 of 1 Trailblazers are 0 for 0 with 20.0 overs left Supernovas
In response to the statement, Osterholm critiqued the WHO for not repudiating its previous estimate of 2 million to 7 million deaths and for not presenting at least a range of mortality numbers that could guide health policymakers. “Even in the best case scenarios of the next pandemic, 2 to 7 million people would die and tens of millions would require medical attention. If the next pandemic virus is a very virulent strain, deaths could be dramatically higher.” “Because of these factors, confidently narrowing the range of estimates cannot be done until the pandemic emerges,” the WHO said. “Therefore, response plans need to be both strong and flexible. Dec 9, 2004 (CIDRAP News) The World Health Organization weighed in yesterday on the debate about the potential magnitude of the next influenza pandemic by saying it’s impossible to confidently predict how many lives a pandemic might claim. Estimates based on previous pandemics “are problematic because the world in 2004 is a different place from 1918. The impact of greatly improved nutrition and health care needs to be weighed against the contribution the increase in international travel would have in terms of global spread.” “Experts’ answers to this fundamental question” of the likely scale of a pandemic “have ranged from 2 million to over 50 million,” the WHO said. “All these answers are scientifically grounded. The reasons for the range are manyfold.” The WHO and flu experts around the world are worried that the widespread H5N1 avian influenza in Asia could spark a human flu pandemic, conceivably on the scale of the devastating Spanish flu pandemic of 1918-1920, which killed an estimated 20 million to 50 million people. The level of preparedness will influence the death toll. US Health and Human Services (HHS) Secretary Tommy Thompson, in announcing his resignation plans last week, cited what he said was a WHO estimate that a pandemic could cause 30 million to 70 million deaths. Important details about past pandemics, including death tolls, are disputed. Even for the most recent pandemic, in 1968, estimates range from 1 million to 3 million deaths. On the lower end of the scale is a 1999 estimate cited in HHS’s pandemic preparedness plan, released in August. It said that a pandemic could cause up to 207,000 deaths in the United States. If the global death rate were the same as in the United States, that would mean a world toll of roughly 4.4 million. The WHO today listed four reasons why it’s hard to predict how bad a flu pandemic might be: The characteristics of a future pandemic virus can’t be predicted. It could affect anywhere from 20% to 50% of the population. No one knows how pathogenic the virus would be or which age-groups it would affect. Henry L. Niman, a Pittsburgh medical researcher who is described as a critic of the WHO, said a pandemic could conceivably kill a billion people if the 72% mortality rate seen in recent confirmed human H5N1 cases prevailed, according to a Nov 29 New York Times report. In the same story, Klaus Stohr, chief of the WHO’s influenza program, rejected Niman’s estimate as unscientific and unjustified, saying the H5N1 death rate may be overstated because less severe cases might have gone undiagnosed. Osterhom asserted that the WHO should explore “a wide range of numbers that reflect what would be considered a relatively mild world pandemic to what could realistically be considered a serious world pandemic . . . if for no other reason than that planners could get a sense of the morbidity and mortality they need to address in their plans. In short, the WHO needs to do more to provide better definition even in the context of a “While it is impossible to accurately forecast the magnitude of the next pandemic, we do know that much of the world is unprepared for a pandemic of any size,” the WHO said in a prepared statement. At the same time, the agency said a pandemic virus could “affect between 20-50% of the total population.” The agency went on to say it will convene a meeting on preparedness planning next week and will publish an assessment tool in the next few weeks “to evaluate and focus national preparedness efforts.” Many WHO member countries have not even begun to plan for a pandemic, the statement added. Some other experts have gone higher. Disease expert Michael T.Osterholm, PhD, MPH, has estimated publicly that a pandemic could kill up to 1.7 million people in the United States and as many as 177 million worldwide. Osterholm is director of the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP), publisher of this Web site. He said current global deaths from ordinary flu total roughly 1.8 million every 2 years, which is about how long a pandemic would be expected to last. Therefore, “No one believes 2 million to 7 million is a remotely realistic situation” in a pandemic, he said. Until recently the WHO had been estimating the possible global death toll in a potential pandemic at 2 million to 7 million. But in a Nov 29 speech, Dr. Shigeru Omi, the WHO’s Western Pacific regional director, said that a pandemic could kill 20 million to 50 million people, or even up to 100 million.
Aug 14, 2006 (CIDRAP News) – A World Health Organization (WHO) reference laboratory confirmed today that a 62-year-old Chinese man from the far northwestern province of Xinjiang who died Jul 12 had H5N1 avian influenza. The WHO also confirmed another H5N1 case in Indonesia.The Chinese man developed symptoms Jun 19, according to a WHO update today, and initial tests were negative. Tests repeated in July and August, however, produced positive results.Investigators did not find that the patient had a history of exposure to dead or diseased birds or a history of travel the month before he became sick. No recent poultry outbreaks had been reported near the man’s home, and Xinjiang province has not recorded any previous human cases.However, the Chinese news agency Xinhua reported today that an outbreak of avian influenza occurred in Aksu City, in west central Xinjiang, Jul 14. The Chinese Ministry of Health told Xinhua News that 3,045 chickens died from the disease and that 356,976 chickens were culled when the outbreak was confirmed.”There was no confirmed link to poultry, but that doesn’t mean there wasn’t any contact,” Roy Wadia, Beijing-based WHO spokesperson, told Agence France-Presse (AFP) today.”Most of the cases on the Chinese mainland have not had any confirmed link to poultry,” he said in today’s AFP story, adding, “Migratory birds fly across much of China, including Xinjiang. Everything is possible.”The WHO announcement brings China’s official human H5N1 total to 21 cases, which includes 14 fatalities.Last week the WHO and China confirmed the country’s 20th case and its 13th death when it retroactively confirmed the death of a 24-year-old Beijing man who was found to have died of H5N1 in 2003. The cause of his death was reported by Chinese researchers in the Jun 22 issue of the New England Journal of Medicine.Meanwhile, in Indonesia a 17-year-old boy has tested positive for H5N1 avian influenza, which represents the country’s 57th case, according to another WHO update today.The boy, from a remote village in the Garut district in West Java province, developed symptoms Jul 26 and was referred to a hospital on Aug 9 where he was tested because the staff determined he had respiratory symptoms and a history of exposure to dead chickens. A positive result came back Aug 12, and the patient is recovering, according to the WHO update.Bloomberg News reported today that the boy has not been hospitalized for his illness because health authorities haven’t been able to reach him to tell him about his test results. A health ministry official said there is no telephone connection in the boy’s village and that a team had been sent to locate him.The AFP, Associated Press, and Reuters, however, reported today that the boy refused hospitalization. An AFP report today said that he remains under 24-hour medical surveillance at home.Investigators found that chicken and duck deaths had occurred in the patient’s household and neighborhood a week before he became ill. The patient reportedly had contact with diseased chickens during the disposal of their carcasses.Also, investigators collected information on the death of a 20-year-old man who was the boy’s neighbor. The man became ill on Jul 26 and sought medical care at the local health center on Aug 5. He died of respiratory disease on Aug 6 before he could be transferred to a hospital and before samples could be taken for testing. The cause of his illness and death remains undetermined.The boy’s illness brings Indonesia’s confirmed human H5N1 count to 57 cases and 44 deaths. Indonesia had two other avian flu cases in August, and both were fatal: one in a 16-year-old boy and one in a 17-year-old girl.Worldwide, human cases of H5N1 avian flu have reached 238, including 139 deaths.See also: Aug 14 WHO update on China situationhttp://www.who.int/csr/don/2006_08_14/en/index.htmlAug 14 WHO update on Indonesia situationhttp://www.who.int/csr/don/2006_08_14a/en/index.html
Feb 6, 2007 (CIDRAP News) – Two new human cases of H5N1 avian influenza were announced by Indonesia’s health ministry today, as the World Health Organization (WHO) confirmed Egypt’s latest case.One of Indonesia’s patients is a 15-year-girl from an upscale Jakarta neighborhood who caught a wild bird that died 2 days later, Joko Suyono, a spokesperson for the health ministry’s bird flu information center, told Reuters today. He said the other patient is a 30-year-old man from West Java province neighborhood where chicken deaths had been reported.If the WHO confirms the patients’ avian flu status, they will become Indonesia’s 82nd and 83rd cases.Avian flu has taken a heavy toll on Indonesia already this year; the disease has claimed six lives. To slow the spread of the disease, Indonesian authorities banned backyard poultry in Jakarta and planned to begin a massive cull throughout the urban area on Feb 1. However, it’s not known if any progress has been made because of widespread flooding in the city, according to several media reports.Meanwhile, the WHO today confirmed a 17-year-old Egyptian girl’s death from avian influenza. The girl was from Fayyoum governate, about 60 miles south of Cairo. She developed symptoms on Jan 25 and was initially treated for seasonal influenza. On Feb 1 she was hospitalized with fever and breathing difficulties and died the next day, the WHO reported. The girl becomes Egypt’s 20th case and its 12th death.An initial investigation found that there were sick and dead poultry in the girl’s home before she got sick, the WHO said.In other avian flu news, officials at Britain’s Health Protection Authority announced today that a man who helped respond to a recent H5N1 outbreak at a turkey farm in Suffolk was hospitalized today with a mild respiratory illness and is undergoing tests, the Associated Press reported.Britain’s first H5N1 outbreak claimed 2,500 turkeys and led to the culling of about 150,000 others.Agriculture officials in Pakistan today announced an H5N1 avian flu outbreak in poultry in a town near the capital Islamabad, Reuters reported. The outbreak involved 40 chickens at a home, and all died or were culled, Mohammad Afzal, Pakistan’s livestock commissioner, told Reuters.According to the United Nations Food and Agriculture Organization (FAO), Pakistan’s last confirmed outbreak occurred in April 2006 and affected domestic poultry. The country has reported no human cases.See also:Feb 6 WHO statementhttp://www.who.int/csr/don/2007_02_06/en/index.htmlNov 22, 2006, FAO avian flu bulletin with chart of H5N1 outbreaks by countryhttp://www.fao.org/docs/eims/upload/217700/aidenews_nov06_no44.pdf
Feb 16, 2007 (CIDRAP News) – The live-virus, intranasal influenza vaccine FluMist strongly outperformed conventional killed-virus vaccines in a study involving close to 8,000 children younger than 5 years, a finding that may help pave the way for US approval of the vaccine for that age-group.In the international trial conducted in the 2004-05 flu season, there were almost 55% fewer cases of flu in children who received FluMist than in those who received the conventional injectable vaccine, according to a report published in the Feb 15 New England Journal of Medicine (NEJM). The live vaccine worked better than the conventional ones regardless of how well the vaccines matched the circulating viruses.”It’s a pretty convincing result,” commented vaccine expert John Treanor, MD, of the University of Rochester (New York), who was not involved in the research.On the downside, 6- to 11-month-old children in the FluMist group had significantly more hospitalizations for any reason after vaccination and also had a few more episodes of wheezing than their counterparts in the other group.FluMist is currently licensed for use in healthy people between the ages of 5 and 49. On the basis of their findings, the authors, led by Robert B. Belshe, MD, of St. Louis University, conclude that the vaccine is effective and safe for children from 12 to 59 months old with no history of asthma or wheezing.The Centers for Disease Control and Prevention (CDC) currently recommends annual flu vaccination for children from 6 through 59 months old, among other groups considered to have an increased risk of serious complications from flu. Only inactivated, injectable vaccines are licensed for that age-group.FluMist, made by MedImmune Inc., based in Gaithersburg, Md., has been on the market since 2003, but demand for it has been hampered by a higher cost than conventional vaccine and by the requirement to keep it frozen during storage. Last month the Food and Drug Administration (FDA) approved a new formulation that requires refrigeration but not freezing. The refrigerator-stable formulation was used in the new study.MedImmune, which sponsored the study, submitted preliminary results to the FDA in July 2006 with a request to permit use of the vaccine in children aged 1 through 4 years with no history of wheezing, according to Jamie Lacey, a company spokeswoman in Gaithersburg. She called the study “the pivotal trial” supporting the request.The company expects to hear an initial response from the FDA by May 28, Lacey told CIDRAP News. “We’re prepared for approval of this expanded indication for next [flu] season. That’s what we’re gearing up for,” she said.Study included 16 countriesThe study involved 249 physcians’ offices and clinics in 16 countries, with about half of the sites in the United States. The researchers recruited more than 8,300 children, of whom 7,852 completed the study. Children with a history of severe asthma or a recent history of wheezing were excluded, but those with mild or moderate asthma were included.Both FluMist and the injectable vaccines used in the trial, made by Aventis Pasteur, contained the three virus strains recommended by the FDA for the 2004-05 season. In equal numbers, children were randomly assigned to receive either FluMist or the injectable vaccine, and each participant also received a placebo version of the other vaccine (FluMist recipients received dummy injections, and injectable-vaccine recipients received a placebo dose of nasal spray). Participants and medical workers were blinded to the treatment assignments.The researchers reported 153 cases of flu in the FluMist group, for an attack rate of 3.9%. This was 54.9% lower than the 338 cases in the conventional vaccine group, with an attack rate of 8.6% (P<.001). For culture-confirmed flu cases, the attack rates were 5.0% for the FluMist group and 10.0% for the inactivated vaccine group.The live vaccine worked well against both well-matched and mismatched flu strains. Compared with the inactivated-vaccine group, the FluMist group had 89.2% fewer cases of influenza A/H1N1, a strain for which the vaccine was well-matched, and 79.2% fewer cases of A/H3N2, which the vaccine did not match well, the report says. Both differences were significant.The 2004-05 season saw several strains of influenza B, of which some matched the vaccine and some did not. The FluMist group had 16.1% fewer cases of type B flu than the other group, a nonsignificant difference.As for vaccine safety, 6.1% of FluMist recipients between 6 and 11 months old were hospitalized for any cause within 180 days after vaccination, versus 2.6% of children in that age range who received inactivated vaccine, a significant difference. There was no significant difference in hospitalization rates between the two groups overall.The investigators also noted that among children who had a history of wheezing, there was a trend toward a higher rate of all-cause hospitalization among 6- to 47-month-olds in the FluMist group, though it was not significant.The researchers found no significant difference between the two groups in the overall rate of wheezing episodes. But among previously unvaccinated children, 3.8% of FluMist recipients aged 6 to 11 months had a wheezing episode within 42 days after their first vaccine dose, as compared with 2.1% of the same age-group among inactivated vaccine recipients (P=.076). The episodes occurred in the second, third, and fourth weeks after vaccination, after the peak of viral replication, the report says.Overall, the authors write, the findings suggest that FluMist can play an important role in controlling flu. "On the basis of our results, the risk-benefit ratio for live attenuated vaccine appears favorable among children 12 to 47 months of age who have no history of wheezing."Until additional data are available, the observations related to medically significant wheezing and rates of hospitalization will restrict the use of live attenuated vaccine in children younger than 1 year and in children 12 to 47 months of age who have a history of asthma or wheezing," the report states.Though 'definitive,' study lacked placebo groupTreanor, a veteran vaccine researcher and professor of medicine, microbiology, and immunology, commented, "I think one of the things about the study that's remarkable is how carefully done it was and its size. It's quite definitive."He said the study strengthens his general impression that the immune response to live attenuated flu vaccines varies with age. "It really does look like younger children support the replication of the cold-adapted [intranasal] virus more than do adults," leading to a stronger immune response, he commented.Evidence about immune responses and the ability of the vaccine virus to replicate in the nose suggests that the live vaccine probably works better than inactivated vaccine in children, Treanor said. In young and middle-aged adults it appears that the two types are roughly equivalent, though the live vaccine may be slightly better, while inactivated vaccine seems to work better in elderly people, he added."This all reflects the impact of the host on the ability of the live vaccine to replicate and induce an immune response," Treanor said. He said the immunogencity of live vaccines "starts to tail off as you get older and have been exposed to the flu many times," though it's not clear where the age boundaries are.Treanor also commented that in the FluMist study, the flu attack rate of 8.6% in the inactivated-vaccine group is "a reminder that flu vaccines are not perfect in young kids."One limitation of the FluMist study is that the investigators "did not feel they should include a placebo group," Treanor said. That limits the ability to assess the relative benefits of FluMist and the conventional vaccine as compared with no vaccine—a point also made in a NEJM editorial by Nancy J. Cox, PhD, and Carolyn Buxton Bridges, MD, of the CDC."It's hard to have a placebo group in a population where a vaccine is already recommended as a routine step," Treanor said. "But this gap in the knowledge will make it harder for policy makers."For example, he said, the CDC's Advisory Committee on Immunization Practices may eventually want to consider making a specific recommendation about the use of FluMist in small children. Given the likelihood of cost differences and safety issues to consider, "the lack of a placebo group will make that decision more difficult," he said.In their editorial, Cox and Bridges say the live attenuated vaccine may offer "significant advantages" for children, because it doesn't involve needles and may provide better protection against flu than conventional vaccines do."However, enthusiasm for the vaccine must be tempered" by the signs of an increased risk of wheezing and of hospitalization in children less than 1 year old, they write. Although the results are "encouraging, further discussion and careful review of the safety data" will be necessary before policy decisions are made, they add.Belshe RB, Edwards KM, Vesikari T, et al. Live attenduated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007 Feb 15;356(7):685-96 [Abstract]Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children—how do they compare? (Editorial) N Engl J Med 2007 Feb 15;356(7):729-31See also:Jan 9, 2007, CIDRAP News story "FDA approves refrigerated form of FluMist"
Jan 14, 2008 (CIDRAP News) – An official from Indonesia’s health ministry said today that a 32-year-old woman who lived near Jakarta died of H5N1 avian influenza, according to news reports.Suharda Ningrum, of the health ministry’s bird flu center, said the woman, who was from Tangerang on the western outskirts of Jakarta, died at her home on Jan 10, a day after her family took her out of the hospital, Reuters reported today. If the woman’s illness and death are confirmed by the World Health Organization (WHO), she will be listed as the country’s 118th case-patient and its 95th fatality from H5N1.The woman’s samples were sent for testing to two different laboratories, and both confirmed that the woman had the H5N1 virus, the Reuters report said.She had recently purchased a live chicken and eggs from a market and cooked them, Ningrum said. Also, he said poultry were living in the woman’s back yard.Several of Indonesia’s H5N1 case-patients were from Jakarta suburbs. In early 2007 Indonesia banned backyard poultry in Jakarta and announced a widespread culling plan. However, it appears the ban has been difficult to enforce, and officials in some suburbs of Jakarta have said the ban and culling are unrealistic and too costly.The 16-year-old girl confirmed by the WHO on Jan 11 as Indonesia’s most recent H5N1 case-patient is also from a suburban area near Jakarta and reportedly had chickens in her neighborhood, according to previous reports. An official at the hospital where the girl is being treated said her condition was stable but she was still on a respirator, according to today’s Reuters report.See also:Jan 19, 2007, CIDRAP News story “Asian countries struggle to contain avian flu”
Google released a car on the street last month that takes new images for Google Street View, which will be the first major update of this service in 8 years.The car has 8 cameras specially designed for this purpose by Steve Silverman, which worked cameras for NASA’s rovers to Mars. Given that the existing footage on Street View is from the past decade and how much technology has advanced in the meantime, the new footage, which has just begun to arrive, will be in far higher resolution and clearer colors.In addition to beautiful images, the new cameras will send HD images of buildings and street signs for Google’s photo recognition algorithm. More and better quality images from the new hardware now on top of Google Street View will allow the system to make space information much better and more reliable. ”From the point of view of machine learning, we are getting better ” points out Andrew Lookingbill, a technology engineer working for Wired.com, and adds that they are considering trying to automatically recognize different types of jobs from their appearance and read smaller information such as opening hours signs.Take a look at what the new shots look like here
The Tourist Board of the Municipality of Rogoznica strives to keep pace with the development of the most modern technology in every respect, including in the case of destination promotion.It is one of the first in Croatia to implement a project of a virtual walk through the entire municipality, adapted for use with virtual glasses, which with the original sound recorded at each location gives the user a complete experience as if he were literally there. Virtual interactive walk through Rogoznica in 360 degrees is a modern and innovative audiovisual display of the municipality of Rogoznica in a way that allows users to interact with the service by simplifying orientation through natural, historical and cultural sights that preserve an important part of Rogoznica’s identity.The project is a step towards modern technological solutions such as innovative VR (virtual reality) technology and 3D audio that is implemented as an integral part of each individual spherical display creating a complete experience of the displayed space integrated into a virtual panoramic display. Marijo Mladinić, director of the Rogoznica Tourist Board and adds that this sets the project apart from the already seen interactive presentations and acquires a dimension of uniqueness in relation to already implemented multimedia projects in Croatia and Europe. “Every year we try to take a step forward in the promotion of our destination, and we are therefore extremely pleased to have successfully implemented the project of a virtual walk through Rogoznica at such a high level, which I believe has launched a new trend of destination promotion in Croatia. This type of presentation of the destination offers great opportunities and I am sure it will significantly help in attracting new guests to the destination, but also returning old guests who will now be able to literally walk from their living room to all our most interesting sites and bring back their fond memories. lived there and for which it is worth returning here again. I see a particularly high efficiency of this presentation at tourism fairs and I believe that virtual glasses and similar equipment will become an integral part of the standard equipment of every exhibition stand in the future.” Mladinić pointed out and added that with the help of this technology, their future guest can currently be ‘teleported’ from the fair hall directly to their destination, which will certainly not leave him indifferent.The virtual walk is adapted for use on all devices connected to the Internet, without the need to install additional applications or programs. You can try what it is about at the link:https://www.360split.com/virtualne-setnje360/turisticka-zajednica/rogoznica/responsive/Related news: TZ ROGOZNICA – BLUE COW OF OUR TOURISM